252270 Disaster's Impact on the Tohoku Region

Tuesday, November 1, 2011: 10:50 AM

Yoshimi Furuya, MD , Chuhoku Public Health Center, Kofu, Japan
Overview of the Tohoku Earthquake and Tsunami Disaster and the responses of central and local governments of Japan are introduced for the further discussion about what should be done to protect the public against preventable death, communicable and non-communicable diseases in such a complicated disaster of earthquake, tsunami and atomic accident. The strong will for revitalization even in the never-ending sorrow of the tremendous loss to the nation has been uniting Japanese people since March 11, 2011. Sympathies and emergency assistance from overseas countries and regions have also encouraged Japanese people. Comprehensive public health measures can be achieved through collaboration.

Learning Areas:
Protection of the public in relation to communicable diseases including prevention or control
Public health administration or related administration
Public health or related nursing
Public health or related organizational policy, standards, or other guidelines
Social and behavioral sciences

Learning Objectives:
Describe the events surrounding the earthquake in Japan and its impact on the Tohoku Region. List 2 support policies that have been implemented with special public health reference.

Keywords: Disasters, Recovery

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am qualified to give this presentation because I have collected the information of the facts and supports concerning earthquake, tsunami, and Fukushima atomic power plant accident as the Chairman of the Japan Public Health Association and have delivered those information to the whole Directors of Public Health Centers in a country, which was the invaluable data bases to organize the support actions to be sent from the areas where the Directors work.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.